Clinical biomarkers such as cardiac troponin (cTn), B-type natriuretic peptide (BNP), and N-terminal pro-BNP (NT-proBNP) are widely used in the diagnosis of MI and HF (5–7). This evidence concerns the gene NPPB and hydrops fetalis.